Codexis, Inc. (CDXS): Price and Financial Metrics


Codexis, Inc. (CDXS)

Today's Latest Price: $14.41 USD

0.20 (1.41%)

Updated Oct 23 4:00pm

Add CDXS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 384 in Biotech

See all "A" rated Strong Buy stocks

CDXS Stock Summary

  • With a one year PEG ratio of 6,772.37, Codexis Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 99.6% of US stocks.
  • CDXS's price/sales ratio is 11.73; that's higher than the P/S ratio of 88.07% of US stocks.
  • CDXS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 22.36% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Codexis Inc, a group of peers worth examining would be HRTX, AMOT, AMSWA, ICCC, and QUIK.
  • CDXS's SEC filings can be seen here. And to visit Codexis Inc's official web site, go to www.codexis.com.

CDXS Stock Price Chart Interactive Chart >

Price chart for CDXS

CDXS Price/Volume Stats

Current price $14.41 52-week high $18.87
Prev. close $14.21 52-week low $8.43
Day low $14.18 Volume 273,700
Day high $14.47 Avg. volume 376,162
50-day MA $12.94 Dividend yield N/A
200-day MA $12.53 Market Cap 852.02M

Codexis, Inc. (CDXS) Company Bio


Codexis, Inc. develops biocatalysts for the pharmaceutical and fine chemicals markets in the United States and internationally. The company offers Codex biocatalyst panels and kits to pharmaceutical companies that are engaged in drug development and the marketing of approved drugs to allow them to screen and identify possible enzymatic manufacturing processes for their drug candidates and their marketed products. The company was founded in 2002 and is based in Redwood City, California.


CDXS Latest News Stream


Event/Time News Detail
Loading, please wait...

CDXS Latest Social Stream


Loading social stream, please wait...

View Full CDXS Social Stream

Latest CDXS News From Around the Web

Below are the latest news stories about Codexis Inc that investors may wish to consider to help them evaluate CDXS as an investment opportunity.

Codexis to Hold Second Quarter 2020 Conference Call on August 6

REDWOOD CITY, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report second quarter 2020 financial results after market close on Thursday, August 6, 2020. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss financial results and provide a company update. We encourage participants to pre-register for the conference call using the following link: http://dpregister.com/10146500. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.Those without intern...

Yahoo | July 30, 2020

Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis

Partnership targets accelerating the commercialization of enzymatic DNA synthesis: Codexis invests cash and protein engineering for equity stake in Molecular Assemblies

GlobeNewswire | June 23, 2020

Hedge Funds Are Selling Codexis, Inc. (CDXS)

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]

Yahoo | June 22, 2020

Codexis Announces the Election of New Directors at its Annual Meeting of Stockholders

REDWOOD CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of…

GlobeNewswire | June 16, 2020

Edited Transcript of CDXS.OQ earnings conference call or presentation 7-May-20 8:30pm GMT

Q1 2020 Codexis Inc Earnings Call

Yahoo | June 14, 2020

Read More 'CDXS' Stories Here

CDXS Price Returns

1-mo 23.37%
3-mo 26.07%
6-mo 25.30%
1-year 8.18%
3-year 110.36%
5-year 344.75%
YTD -9.88%
2019 -4.25%
2018 100.00%
2017 81.52%
2016 8.75%
2015 67.86%

Continue Researching CDXS

Here are a few links from around the web to help you further your research on Codexis Inc's stock as an investment opportunity:

Codexis Inc (CDXS) Stock Price | Nasdaq
Codexis Inc (CDXS) Stock Quote, History and News - Yahoo Finance
Codexis Inc (CDXS) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9423 seconds.